Сlinical and laboratory features of vaccination against COVID-19 in pregnant women

Mamajonova Diyorakhon, Shukurov Farkhad

dc.contributor.author	Mamajonova Diyorakhon, Shukurov Farkhad
dc.date.accessioned	2022-10-09T06:39:56Z
dc.date.available	2022-10-09T06:39:56Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2704
dc.description.abstract	Тo evaluate the safety, efficacy, and immunogenicity of COVID-19 vaccination in pregnant women. Materials and research methods. The study included 120 pregnant women vaccinated with the Gam-Kovid-Vak vaccine against COVID-19. Of these, 60 women were vaccinated in the second trimester of pregnancy (main group I) and 60 in the third trimester of pregnancy (main group II), and the comparison group consisted of 30 pregnant women who refused vaccination.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Узбекистан, Ташкент	en_US
dc.subject	Coronavirus infection Pregnancy Vaccination Gam-Kovid-Vak vaccine Reactogenicity Immunogenicity	en_US
dc.title	Сlinical and laboratory features of vaccination against COVID-19 in pregnant women	en_US
dc.type	Article	en_US